It is the only vaccine approved by the FDA for monkeypox and the first live, non-replicating vaccine to prevent both diseases.
Jynneos, approved for adults, will be available to those determined to be at high risk of acquiring smallpox or monkeypox.
More articles on pharmacy:
World Pharmacist Day promotes use of safe and effective medicines
USP delays release of updated compounding standards
Americans pay up to 67 times more for drugs than other countries